What was the overall market valuation of the US unnatural amino-acids market in 2024?

The overall market valuation was $633.0 Million in 2024. Read More

What is the projected market valuation for the US unnatural amino-acids market in 2035?

The projected valuation for 2035 is $605.69 Million. Read More

What is the expected CAGR for the US unnatural amino-acids market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is -0.4%. Read More

Which companies are considered key players in the US unnatural amino-acids market?

Key players include Ajinomoto Co Inc, Evonik Industries AG, Fufeng Group Ltd, and others. Read More

What were the valuations for D-Amino Acids & Derivatives in 2024?

The valuation for D-Amino Acids & Derivatives was $63.3 Million in 2024. Read More

How did the valuation for Cancer applications in the US unnatural amino-acids market change from 2024 to 2025?

The valuation for Cancer applications decreased from $200.0 Million in 2024 to $190.0 Million in 2025. Read More

What is the market valuation for Pharmaceutical & Biotechnological Companies in 2024?

The market valuation for Pharmaceutical & Biotechnological Companies was $400.0 Million in 2024. Read More

What were the valuations for Gamma-Amino Butyric Acid (GABA) in 2024?

The valuation for Gamma-Amino Butyric Acid (GABA) was $63.3 Million in 2024. Read More

What is the projected valuation for Research Laboratories in 2035?

The projected valuation for Research Laboratories in 2035 is $225.69 Million. Read More

How did the valuation for Inflammatory Diseases applications change from 2024 to 2025?

The valuation for Inflammatory Diseases applications decreased from $180.0 Million in 2024 to $170.0 Million in 2025. Read More

US Unnatural Amino Acids Market

US Unnatural Amino Acids Market Research Report: By Type (D-Amino Acids & Derivatives, DL-Amino Acids & Derivatives, B-Amino Acids & Derivatives, Cyclic Amino Acids & Derivatives, L-Amino Acid Derivatives, Gamma-Amino Butyric Acid, Gamma-Amino-Beta-Hydroxybutyric Acid, Synthetic-Amino Acids, Others), By Application (Liver Diseases, Cancer, Inflammatory Disease, Genetic Diseases) and By End User (Pharmaceutical & Biotechnological, Companies, Research Laboratories) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

0.4%

2024 Market Size

$ 633 Million

2035 Market Size

$ 605.69 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/12138-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 D-Amino Acids & Derivatives
  2. 4.1.2 DL-Amino Acids & Derivatives
  3. 4.1.3 B-Amino Acids & Derivatives
  4. 4.1.4 Cyclic Amino Acids & Derivatives
  5. 4.1.5 L-Amino Acid Derivatives
  6. 4.1.6 Gamma-Amino Butyric Acid (GABA)
  7. 4.1.7 Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)
  8. 4.1.8 Synthetic-Amino Acids
  9. 4.1.9 Others
2. 4.2 Chemicals and Materials, BY Application (USD Million)
  1. 4.2.1 Liver Diseases
  2. 4.2.2 Cancer
  3. 4.2.3 Inflammatory Diseases
  4. 4.2.4 Genetic Diseases
3. 4.3 Chemicals and Materials, BY End-User (USD Million)
  1. 4.3.1 Pharmaceutical & Biotechnological Companies
  2. 4.3.2 Research Laboratories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Ajinomoto Co Inc (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Evonik Industries AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fufeng Group Ltd (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Kyowa Hakko Bio Co Ltd (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Nutraceutical International Corp (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 SAB Biotherapeutics Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Shaanxi Sciphar Hi-Tech Industry Co Ltd (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sino Lion (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Unnatural Amino Acids Market Segmentation

US Unnatural Amino Acids Market By Type (USD Million, 2025-2035)

D-Amino Acids & Derivatives
DL-Amino Acids & Derivatives
B-Amino Acids & Derivatives
Cyclic Amino Acids & Derivatives
L-Amino Acid Derivatives
Gamma-Amino Butyric Acid (GABA)
Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)
Synthetic-Amino Acids
Others

US Unnatural Amino Acids Market By Application (USD Million, 2025-2035)

Liver Diseases
Cancer
Inflammatory Diseases
Genetic Diseases

US Unnatural Amino Acids Market By End-User (USD Million, 2025-2035)

US Unnatural Amino Acids Market & Biotechnological Companies
Research Laboratories

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”